Natural Killer Cells: From Basic Research to Treatments

January 1, 2011Frontiers in ImmunologyOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

Outline the fundamental biological questions and clinical translation hurdles facing natural killer and innate lymphoid cell research.
Synthesizes emerging paradigms in innate lymphoid cell biology and frames core priorities for translational cellular immunotherapy.
Identifies critical gaps between mechanistic understanding of natural killer cell receptor signaling and effective in vivo therapeutic control.
Highlights clinical potential for harnessing natural killer cells against malignancies and infectious diseases through targeted immunotherapies.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Expert perspective highlights translational challenges in natural killer cell biology, suggesting strategies to accelerate innate cell therapies.

No takes yet. Share an insight, caveat, or question.

Vivier et al. (2011) studied this question.

View Full Paper

Ask AI

Bookmark

Share